Brief: Immunome Reports First Quarter 2022 Financial Results
12/05/2022 13:28
May 12 (Reuters) - Immunome Inc IMNM.O :
* IMMUNOME REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
* QTRLY LOSS PER SHARE $0.96
* AS OF MARCH 31, 2022, CASH AND CASH EQUIVALENTS TOTALED
$42.9
MILLION
Source text for Eikon: ID:nBw9hKfL9a
Further company coverage: IMNM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Immunome
See all newsBrief: Immunome - Enters Amendment No. 4 To License Agreement With Bristol-Myers Squibb Company On Oct 2, 2026
US STOCKS ON THE MOVE-Cardinal Health, nVent, Acuity
U.S. STOCKS ON THE MOVE-Cardinal Health, Fervo Energy, Rocket Lab
U.S. STOCKS ON THE MOVE-Progress Software, Vicor Corp, Accenture
Immunome climbs as Stifel initiates coverage